---
title: "PRECISE: SG100K Driver Projects"
permalink: /precise-sg100k-driver-projects/
variant: tiptap
description: ""
third_nav_title: Our Data Users
---
<h4><strong>Computation of genome - wide LD scores and matrices from the SG100K resource</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Li Jingmei</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Rajkumar s/o Dorajoo</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Khor Chiea Chuen </strong>A*STAR Genome Institute
of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Taking reference from similar work performed by the Pan-UK Biobank, the
team will compute in-sample dosage-based LD matrices and scores for each
of the three major ancestry groups in SG100K:
<br>- LD score regression analysis to estimate heritabilities
<br>- Fine-mapping analysis to identify causal variants of well-powered complex
traits</p>
</li>
<li>
<p>The plan is to make the LD matrices available in Hail's BlockMatrix format
or similar. LD scores are also made available in LDSC-compatible flat files
(.l2.ldscore.gz and .M_5_50).</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Genome Institute of Singapore</p>
<hr>
<h4><strong>Chronic liver disease is a significant risk factor for adverse cardiometabolic outcomes</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Mark Chan</strong>
<br>National University Hospital
<br>Cardiology</p>
</li>
<li>
<p><strong>Co-Lead PI: Dr Nicholas Chew</strong>
<br>National University Hospital
<br>Cardiology</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Investigate associations between established non-invasive Chronic Liver
Disease (CLD) biomarkers and cardiometabolic outcomes.</p>
</li>
<li>
<p>Evaluate how these associations relate to major adverse cardiac events.</p>
</li>
<li>
<p>Examine whether these associations with CLD are independent from associated
metabolic disease.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> National University Hospital</p>
<hr>
<h4><strong>Nonlinear methods for genomic association analysis of eye diseases</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Liu Dianbo</strong>
<br>National University of Singapore
<br>Ophthamology</p>
</li>
<li>
<p><strong>Co-Lead PI: A/P Wee Hwee Lin</strong>
<br>National University of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Dr Nicolas Bertin</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Identify non-linear genetic associations contributing to \ the susceptibility
and manifestation of diverse eye diseases.</p>
</li>
<li>
<p>Explore epistatic interactions and allelic heterogeneity within the genomic
data to unravel the complex relationships between multiple genetic variants.</p>
</li>
<li>
<p>Investigate how non-linear responses to environmental variables contribute
to the phenotypic variation, with a focus on refining our understanding
of gene- environment interactions in the context of ocular health.</p>
</li>
<li>
<p>Investigate and interpret the biological relevance of non-linear genetic
associations. Aim to gain insights into the underlying mechanisms linking
identified genetic variants to specific eye diseases and contribute to
a more comprehensive understanding of the biology involved.</p>
</li>
<li>
<p>Evaluate the public health implications of the identified non-linear genetic
associations, considering their potential impact on disease prevention,
intervention, and personalised treatment strategies. Assess the translational
potential of the research findings to inform clinical practice, public
health policies, and contribute to advancements in precision medicine for
ocular health.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> National University of Singapore</p>
<hr>
<h4><strong>Advancing the understanding of biological mechanisms influencing chronic inflammatory skin diseases</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Yew Yik Weng</strong>
<br>National Skin Centre</p>
</li>
<li>
<p><strong>Co-Lead PI: Steven Thng Tien Guan</strong>
<br>National Skin Centre</p>
</li>
<li>
<p><strong>Co-Lead PI: Marie Loh</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Identify host genetic factors associated with chronic inflammatory skin
diseases, specifically AD, psoriasis and chronic urticaria using genome
wide association and rare variant analyses among SG100K study participants,
taking advantage of whole genome sequence data and linkage to disease information
from national electronic health records (NEHR).</p>
</li>
<li>
<p>Examine the relationship between genetic variants and polygenic risk scores
(PRS) associated with skin phenotypes and real-world health data for skin
diseases (including diagnosis, onset, severity and treatment outcomes)
to identify genetic predictors of disease trajectories, complications and
co-morbidities and treatment outcomes using the TRUST dataset.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> National skin Centre, Lee Kong
Chian School of Medicine, A*STAR Skin Research Institute of Singapore</p>
<hr>
<h4><strong>Mood and diet in patients with irritable bowel syndrome (IBS) in Singapore</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Theresia Mina</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
<li>
<p><strong>Co-Lead PI: Jojn Chambers</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
<li>
<p><strong>Co-Lead PI: Sim Xueling</strong>
<br>National University of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Evaluate the dietary pattern and characteristics of patients with IBS
in Singapore.</p>
</li>
<li>
<p>Identify patterns of mood disorders in patients with IBS in Singapore.</p>
</li>
<li>
<p>Identify genetic variants associated with IBS in the multi-ethnic Singaporean
Population. Explore and characterise common genetic polymorphisms IBS within
the diverse Singaporean population. This comprehensive genetic investigation
aims to unravel the unique genetic landscape of IBS, considering the multi-ethnic
composition of the population.</p>
</li>
<li>
<p>Investigate the effects of lifestyle factors on IBS Risk and progression.
Systematically examine the impact of lifestyle factors, including diet,
physical activity, sleep, stress, and mental health, on the risk and progression
of IBS. This multifaceted investigation seeks to discern the intricate
relationships between lifestyle choices and IBS, contributing valuable
insights for developing targeted interventions and improving patient outcomes.</p>
</li>
<li>
<p>Elucidate potential interactions between genetic and environmental influences
on IBS. Uncover and elucidate potential interactions between genetic factors
and environmental influences in the development and progression of IBS.
This integrated approach aims to provide a nuanced understanding of how
genetic predispositions and environmental exposures collaboratively contribute
to the manifestation of IBS, offering a foundation for personalised and
precision medicine strategies.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> Tan Tock Seng Hospital, Lee Kong
Chian School of Medicine</p>
<hr>
<p></p>
<h4><strong>The contribution of genetics to dietary habit and its relation to adiposity and cardiometabolic diseases in multiethnic Asian population</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Theresia Mina</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
<li>
<p><strong>Co-Lead PI: Jojn Chambers</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
<li>
<p><strong>Co-Lead PI: Sim Xueling</strong>
<br>National University of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Conduct phenotypic associations of macronutrients with visceral adiposity
as primary outcome, and the visceral fat linked cardiometabolic traits
and diseases as secondary outcomes in multiethnic Asian population.</p>
</li>
<li>
<p>Perform GWAS of macronutrients in multiethnic Asian population using the
SG100K dataset and a GWAS meta-analysis using the UK Biobank macronutrient
intake data.</p>
</li>
<li>
<p>Perform functional annotation of significant loci and estimate the genetic
correlations of macronutrient intake with visceral fat linked cardiometabolic
traits and diseases as secondary outcomes.</p>
</li>
<li>
<p>Conduct one-sample and two-sample Mendelian Randomisation (MR) with macronutrient
intake as exposure variables and visceral adiposity as outcome variables,
with relevant sensitivity analyses.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> Lee Kong Chian School of Medicine,
National University Hospital</p>
<hr>
<p></p>
<h4><strong>A structural variation catalogue across three ancestrally diverse Singapore populations</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Joanna Tan Hui Juan</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Shyam Prabhakar</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Patrick Tan Boon Ooi</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Build a catalogue of SVs (deletions, insertions, duplications, inversions,
translocations, and tandem repeats) from the PRECISE-SG100K dataset.</p>
</li>
<li>
<p>Investigate the identified SVs to uncover population-specific trends.</p>
</li>
<li>
<p>Examine the functional consequences of SVs in different genomic regions
as well as predict the impact of SVs in medically relevant genes.</p>
</li>
<li>
<p>Identify SVs that are associated with phenotypic traits within the PRECISE-SG100K
dataset.</p>
</li>
<li>
<p>Elucidate the impact of SVs on variation in cell type-specific gene expression
(SV-eQTLs) and validate SVs through copy number variation inferences from
scRNA-seq data.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Genome Institute of Singapore</p>
<hr>
<h4><strong>Genome-wide association study and population- based evaluation of patients with diabetic foot ulcers</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Joseph Lo</strong>
<br>Woodlands Health</p>
</li>
<li>
<p><strong>Co-Lead PI: Kavita Venkataraman</strong>
<br>National University of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Yusuf Ali</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<p><strong>Primary aim:</strong>
<br>Identify genetic loci associated with diabetic foot ulcers in Asian patients
with diabetes mellitus.</p>
<p></p>
<p><strong>Secondary aims:</strong>
</p>
<ul data-tight="true" class="tight">
<li>
<p>Identify differences in genetic loci within Malay/Indian ethnicities.</p>
</li>
<li>
<p>Identify genetic loci associated with diabetic peripheral neuropathy.</p>
</li>
<li>
<p>Identify potential gene-environment interactions (for example, tobacco
smoking) associated with the risk ofdiabetic foot ulcers.</p>
</li>
<li>
<p>Identify socio-economical and other risk factors associated with diabetic
foot ulcers.</p>
</li>
<li>
<p>Identify correlations between macro-angiopathy, micro-vascular reactivity
nephropathy and retinopathy and diabetic foot ulcers.</p>
</li>
<li>
<p>Develop multi-polygenic risk score for developing diabetic foot ulcers.</p>
</li>
</ul>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> Woodlands Health, National University
of Singapore, Lee Kong Chian School of Medicine</p>
<hr>
<h4><strong>The SG100K_cancer and aging workgroup: Developing risk models for cancer associations</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Joanne Ngeow</strong>
<br>Lee Kong Chian School of Medicine</p>
</li>
<li>
<p><strong>Co-Lead PI: Rajkumar s/o Dorajoo</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Neerja Karnani</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Generate common variant polygenic risk scores for common cancers (breast,
colorectal, liver, lung, and prostate cancers) and identify potential functional
rare coding genetic mutations in strong cancer related genes in the SG100K
dataset.</p>
</li>
<li>
<p>Generate additional age-related biomarkers (i.e as telomere length estimates)
related to cancer risk from the SG100K WGS data and identify genetic predispositions
associated with these biomarkers.</p>
</li>
<li>
<p>Linkage of genetic datasets with TRUST to derive clinical data and determine
common cancer status (breast, colorectal, liver, lung, and prostate cancers).</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> Lee Kong Chian School of Medicine,
A*STAR Genome Institute of Singapore, Bioinformatics Institute</p>
<hr>
<h4><strong>Genetic susceptibility of age-related hearing loss</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Liu Jianjun</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Nicolas Bertin</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Lim Weng Khong</strong>
<br>Duke-NUS Medical School</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Generate a SG100K genome wide TR variation catalogue and characterisation
their respective prevalence in Asian populations.</p>
</li>
<li>
<p>Characterise the contributions of TR variations to the aetiology of complex
neurological and neurocognitive disorders.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Genome Institute of Singapore,
Duke-NUS Medical School</p>
<hr>
<h4><strong>Evaluating the promise and perils of glucagon-like peptide-1 (GLP-1) receptor agonist: a deep dive into therapeutic potentials and adverse effects</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Huang Jian</strong>
<br>A*STAR Singapore Institute for Clinical Sciences and Bioinformatics Institute</p>
</li>
<li>
<p><strong>Co-Lead PI: Dennis Wan</strong>
<br>A*STAR Singapore Institute for Clinical Sciences and Bioinformatics Institute</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Investigate the effects of GLP-1 receptor agonist on various domains of
health outcomes using an observational study design</p>
</li>
<li>
<p>Identify the non-synonymous single nucleotide polymorphisms (SNPs) of
GLP-1 receptor agonist prescription and predict nsSNPs responsible for
the differential response to GLP-1 receptor agonist.</p>
</li>
<li>
<p>Provide genetic evidence for the therapeutic potentials and adverse effects
of GLP-1 receptor agonists by adopting a drug target Mendelian randomisation
design.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Singapore Institute for
Clinical Sciences</p>
<hr>
<h4><strong>Unravelling the pathogenesis of inflammatory bowel disease and associated immune- mediated disorders in the Singaporean population</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: </strong>Sunny Wong
<br>Lee Kong Chian School of Medicine</p>
</li>
<li>
<p><strong>Co-Lead PI: Nicolas Bertin</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Lim Weng Khong</strong>
<br>Duke-NUS Medical School</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Identify Genetic Variants Associated with</p>
<p>IBD and Related Immune-Mediated</p>
<p>Disorders in the Multi-Ethnic Singaporean</p>
<p>Population.</p>
<p>Explore and characterise both common and</p>
<p>rare genetic variants linked to IBD, and</p>
<p>spondyloarthropathies, uveitis, Behcet's</p>
<p>disease, psoriasis, and other related</p>
<p>immune-mediated conditions within the</p>
<p>diverse Singaporean population. This</p>
<p>comprehensive genetic investigation aims</p>
<p>to unravel the unique genetic landscape of</p>
<p>this disease cluster, considering the multi-</p>
<p>ethnic composition of the population.</p>
</li>
<li>
<p>Investigate the Effects of Lifestyle Factors</p>
<p>on IBD and Associated Diseases Risk and</p>
<p>Progression. Systematically examine the impact of</p>
<p>lifestyle factors, including diet, physical</p>
<p>activity, sleep, stress, and mental health, on</p>
<p>the risk and progression of IBD and</p>
<p>associated immune-mediated diseases. This</p>
<p>multifaceted investigation seeks to discern</p>
<p>the intricate relationships between lifestyle</p>
<p>choices and disease outcomes, contributing</p>
<p>valuable insights for developing targeted</p>
<p>interventions and improving patient</p>
<p>wellbeing.</p>
</li>
<li>
<p>Delineate shared and distinct mechanisms</p>
<p>underlying IBD, spondyloarthropathy,</p>
<p>uveitis, psoriasis, Behcet's and other related</p>
<p>conditions.</p>
<p>Elucidate the shared and unique genetic</p>
<p>and biological pathways driving IBD,</p>
<p>spondyloarthropathy, uveitis, psoriasis,</p>
<p>Behcet's disease, and other related</p>
<p>conditions. This will provide critical insights</p>
<p>into disease mechanisms to guide targeted</p>
<p>prevention and treatment strategies for this</p>
<p>nexus of related diseases.</p>
</li>
<li>
<p>lucidate Potential Interactions Between</p>
<p>Genetic and Environmental Influences on</p>
<p>This Disease Cluster.</p>
<p>Uncover and elucidate potential</p>
<p>interactions between genetic factors and</p>
<p>environmental influences in the</p>
<p>development and progression of IBD and</p>
<p>related conditions. This integrated</p>
<p>approach aims to provide a nuanced</p>
<p>understanding of how genetic</p>
<p>predispositions and environmental</p>
<p>exposures collaboratively contribute to the</p>
<p>manifestation of this disease cluster,</p>
<p>offering a foundation for personalised and</p>
<p>precision medicine strategies.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> Lee Kong Chian School of Medicine,
National University of Singapore</p>
<hr>
<h4><strong>Genetic susceptibility of age-related hearing loss2</strong></h4>
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p>Team</p>
</th>
<th rowspan="1" colspan="1">
<p>Aims of Project</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<ul data-tight="true" class="tight">
<li>
<p><strong>Lead PI: Liu Jianjun</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Nicolas Bertin</strong>
<br>A*STAR Genome Institute of Singapore</p>
</li>
<li>
<p><strong>Co-Lead PI: Lim Weng Khong</strong>
<br>Duke-NUS Medical School</p>
</li>
</ul>
</td>
<td rowspan="1" colspan="1">
<ol data-tight="true" class="tight">
<li>
<p>Generate a SG100K genome wide TR variation catalogue and characterisation
their respective prevalence in Asian populations.</p>
</li>
<li>
<p>Characterise the contributions of TR variations to the aetiology of complex
neurological and neurocognitive disorders.</p>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
<p><strong>Institutions involved:</strong> A*STAR Genome Institute of Singapore,
Duke-NUS Medical School</p>
<p></p>
<p></p>
<p></p>